Document is current
Any future updates will be listed below
-
Authors
Gayet, Raphaël V. http://orcid.org/0000-0001-6857-5941
Ilia, Katherine http://orcid.org/0000-0002-7205-5364
Razavi, Shiva http://orcid.org/0000-0001-5536-7350
Tippens, Nathaniel D.
Lalwani, Makoto A.
Zhang, Kehan http://orcid.org/0000-0002-7979-3001
Chen, Jack X.
Chen, Jonathan C.
Vargas-Asencio, Jose http://orcid.org/0000-0002-3577-823X
Collins, James J. http://orcid.org/0000-0002-5560-8246
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01EB024591, 5RC2DK120535)
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 1 July 2022
Accepted: 20 February 2023
First Online: 11 March 2023
Competing interests
: J.J.C. is an inventor on multiple patents that cover RNA riboregulators. He is a cofounder of Synlogic and Senti Biosciences, a cofounder and director of Sherlock Biosciences, and is on the Shape Therapeutics scientific advisory board. R.V.G., K.I., S.R., N.D.T., M.A.L., K.Z., J.X.C., J.C.C., and J.J.C. have filed a provisional patent (with Massachusetts Institute of Technology as the applicant) on covering the DART VADAR circuitry described herein (US Provisional Application Number 63/481,010). The remaining authors declare no competing interests.
